Mid Penn Bank Originates Over $1 Billion in PPP Loans Helping to Save Over 89,000 Jobs

Written by Customer Service on May 5, 2021. Posted in Public Companies.

MILLERSBURG, Pa., May 05, 2021 (GLOBE NEWSWIRE) — Mid Penn Bancorp, Inc. (“Mid Penn”) (NASDAQ: MPB), parent company of the wholly-owned subsidiaries Mid Penn Bank (“Bank”) and MPB Financial Services, Inc., announced today that the Bank has approved and disbursed more than $370 million in loans for small businesses since the 2021 Paycheck Protection Program (PPP) portal was opened for community banks in January. Mid Penn Bank has provided loans for more than 3,300 businesses in the 2021 Program. The Small Business Administration backed loans received by these employers has allowed them to retain more than 34,000 workers on their payrolls. The Bank’s SBA team relied on the experience gained in the first round of PPP in 2020 to help business owners and managers efficiently and successfully apply for and receive this critical funding....

Minerva Neurosciences to Report First Quarter 2021 Financial Results and Business Updates on May 12, 2021

Written by Customer Service on May 5, 2021. Posted in Public Companies.

Management to host conference call WALTHAM, Mass., May 05, 2021 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the first quarter of 2021 on Wednesday, May 12, 2021. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 (domestic) or (765) 507-2618 (international) and referring to conference ID number 8981662. A live webcast of the conference call will be available online in the Investors and Media section of the Company’s website at ir.minervaneurosciences.com. The archived webcast...

Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2021 and Declares Quarterly Dividend

Written by Customer Service on May 5, 2021. Posted in Dividend Reports And Estimates.

TORONTO, May 05, 2021 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the first quarter ended March 31, 2021 and declared a $1.00 per share dividend payable on July 10, 2021 to all common shareholders of record at close of business on June 19, 2021. This dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada). Please note that all dollar amounts referred to in this press release are in U.S. Dollars unless otherwise stated. The following press release should be read in conjunction with the Company’s Unaudited Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2021 and the accompanying notes, our Management Discussion and Analysis for the three months ended March...

Firm Capital Property Trust Announces Closing of Lower Sackville Property Acquisition Comprised of 132 Units for $18.0 Million

Written by Customer Service on May 5, 2021. Posted in Mergers And Acquisitions.

TORONTO, May 05, 2021 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust“) (TSXV: FCD.UN) is pleased to announce the closing of the previously announced acquisition of 132 units in three multi-residential buildings located in Lower Sackville, Nova Scotia (the “Lower Sackville Property”) for approximately $18.0 million (excluding transaction costs). The Lower Sackville Property is located in proximity to downtown Halifax and is conveniently located to schools, public transportation, shopping, restaurants, and entertainment. The Lower Sackville Property has enjoyed strong 98% occupancy rates or higher since 2018. The Lower Sackville Property was purchased for approximately $136,300 per unit or $113 per square foot. The Lower Sackville Property was financed with a new $13.7 million mortgage...

Disclosure of Voting Rights in IDEX Biometrics – Chair Morten Opstad – 5 May 2021

Written by Customer Service on May 5, 2021. Posted in Public Companies.

At the close of business on 5 May 2021, Morten Opstad, Chair of the Board of IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose of the Extraordinary General Meeting on 12 May 2021: Total 172,557,729 shares or 18,82% of the share capital and votes, consisting of the following: Proxy to present and vote for 73,181,240 shares or 7,98% of the share capital, including shares held by Mr Opstad and close relations Proxy with voting instructions for 99,376,489 shares or 10,84% of the share capital. For further information contact: Marianne Bøe, Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: + 47 918 00186 Brett L Perry, U.S. Investor RelationsE-mail: bperry@sheltongroup.comTel: + 1 214 272 0070 About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDXBA) is a leading provider of fingerprint...

DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021

Written by Customer Service on May 5, 2021. Posted in Public Companies.

Montrouge, France, May 5, 2021 DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the filing of its first Form 10-Q for the quarter ended March 31, 2021 with the U.S. Securities and Exchange Commission (SEC). This document can be accessed on the Investors & Media section of the Company’s website at www.dbv-technologies.com. In addition, this Form 10-Q is available on the SEC’s website at www.sec.gov. About DBV Technologies DBV Technologies is developing Viaskin™, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT™, DBV’s method of delivering...

SJI Reports First Quarter 2021 Results

Written by Customer Service on May 5, 2021. Posted in Public Companies.

Investor Day To Provide Long-Term Growth Outlook FOLSOM, NJ , May 05, 2021 (GLOBE NEWSWIRE) — Investor Contact: Daniel Fidell 609-561-9000 x7027 dfidell@sjindustries.com Media Contact: Dominick DiRocco 609-561-9000 x4262 ddirocco@sjindustries.com SJI Reports First Quarter 2021 ResultsInvestor Day To Provide Long-Term Growth Outlook FOLSOM, NJ (May 5, 2021) – SJI (NYSE: SJI) today reported operating results for the first quarter ended March 31, 2021. Highlights include: Q1 2021 GAAP earnings of $1.26 per diluted share compared to $1.09 per diluted share in 2020 Q1 2021 Economic Earnings* of $1.26 per diluted share compared to $1.15 per diluted share in 2020 First quarter results reflect increased profitability from Utility and Non-Utility operations partially offset by impact of financing activities Successful...

Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021

Written by Customer Service on May 5, 2021. Posted in Public Companies.

SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of May. On May 12, 2021, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference at 10:15 a.m. PT. On May 25, 2021, Carl Hull, Chief Executive Officer will participate in a fireside chat at the UBS Global Healthcare Conference at 2:00 p.m. PT. A live webcast of the presentations will be available to all interested parties on the Maravai Lifesciences investor relations website at http://investors.maravai.com. An archived version of the webcast will be available a few hours following the completion...

NextCure to Present at the BofA Securities 2021 Virtual Health Care Conference

Written by Customer Service on May 5, 2021. Posted in Public Companies.

BELTSVILLE, Md., May 05, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the BofA Securities 2021 Virtual Health Care Conference on May 12th at 2:00 pm Eastern time. A live audio webcast will be available through the Investors section of the company’s website at www.nextcure.com. A replay of the webcast will be available after the event and archived on the website for 30 days. About NextCure, Inc.NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through our proprietary...

Chris Larsen hired as Vice President of Engineering at Image Sensing Systems

Written by Customer Service on May 5, 2021. Posted in Public Companies.

ST. PAUL, Minn., May 05, 2021 (GLOBE NEWSWIRE) — Image Sensing Systems, Inc. (NASDAQ: ISNS) announced today that Chris Larsen has been appointed as the company’s Vice President of Engineering. Mr. Larsen will report to Chad Stelzig, company President and CEO. Mr. Larsen has most recently served as Principal Systems Engineer within the Aerospace Advanced Technology group at Honeywell International Incorporated. Prior to Honeywell, Mr. Larsen has held various positions to include Vice President of Engineering and Co-CTO at Prevent Biometrics Incorporated, Sr. Principal Engineering and Research positions within the Sensor and Wireless Research Laboratory and Industrial Safety at Honeywell, and Product Development Engineering at Nonin Medical Incorporated. In total, Mr. Larsen has over 20 years of advanced technology development...

Day: May 5, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice